Joint Formulary & PAD

Dantrolene sodium - Malignant hyperpyrexia (anaesthetic induced)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravenous injection (IV)
Associated Icons :
BNF SPC
R
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Dantrolene sodium
Indication :
Malignant hyperpyrexia (anaesthetic induced)
Group Name :
Keywords :
drug induced hyperthermia
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Dantrolene sodium is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Malignant hyperpyrexia (anaesthetic induced).

  • No records returned.

Committee Recommendations (1)

This drug has been included on the joint formulary having been agreed by the DTC of at least one Surrey Heartlands Acute Trust.

See “Formulary Status” to identify where this drug has been agreed for use.